What is the Share Price of Nath Bio-Genes (India) Ltd?

Nath Bio-Genes (India) Ltd share price is ₹158.00 As on 09 May, 2025|14:35

Home
>
Stocks
>
Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Ltd Share Price

Q: What is the Market Cap of Nath Bio-Genes (India) Ltd?

The Market Cap of Nath Bio-Genes (India) Ltd is ₹306 As on 09 May, 2025|14:35

Q: What is PE Ratio of Nath Bio-Genes (India) Ltd?

The P/E ratio of Nath Bio-Genes (India) Ltd is 58 As on 09 May, 2025|14:35

Q: What is PB Ratio of Nath Bio-Genes (India) Ltd?

The PB ratio of Nath Bio-Genes (India) Ltd is 5.23 As on 09 May, 2025|14:35

₹ 158.00 -3.26 (-2.02%)
Updated on 09-05-2025 2:35 PM

Stock Rating

Pros 1

Cons 8

Nath Bio-Genes (India) Ltd Price Performance

Day's Low
₹156

Day's High
₹160.25

₹ 158

52-w low
₹137.55

52-w high
₹264.31

158

Day's open
₹160.25
Previous close
₹161.259995
VWAP
₹157.7
Lower price band
₹129
Upper price band
₹193.51

Today's Market Action

The last traded share price of Nath Bio-Genes (India) Ltd was 158.00 down by -2.02% on the NSE. Its last traded stock price on BSE was 158.00 down by -1.86%. The total volume of shares on NSE and BSE combined was 12,632 shares. Its total combined turnover was Rs 0.20 crores.

Nath Bio-Genes (India) Ltd Medium and Long Term Market Action

Nath Bio-Genes (India) Ltd hit a 52-week high of 264.31 on 08-07-2024 and a 52-week low of 137.55 on 12-03-2025. The stock price of Nath Bio-Genes (India) Ltd is up by 9% over the last one month. It is down by -22.78% over the last one year. Don't forget to check the full stock price history in the table below.

Nath Bio-Genes (India) Ltd Fundamentals

Market Cap (Cr): 306
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Nath Bio-Genes (India) Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Nath Bio-Genes (India) Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Nath Bio-Genes (India) Ltd

Data not available.

Nath Bio-Genes (India) Ltd FAQ's

What is Share Price of Nath Bio-Genes (India) Ltd?

What is the Market Cap of Nath Bio-Genes (India) Ltd?

What is PE Ratio of Nath Bio-Genes (India) Ltd?

What is PB Ratio of Nath Bio-Genes (India) Ltd?

What is the CAGR of Nath Bio-Genes (India) Ltd?

How to Buy Nath Bio-Genes (India) Ltd Share?

Can I buy Nath Bio-Genes (India) Ltd from Samco?

How do I buy Nath Bio-Genes (India) Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 138.89% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.

Cons

Momentum Strength
The stock is currently exhibiting weak momentum, & is showing weak relative strength.
Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 5.56 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.33. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 364 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
High Promoter Pledge
The company has a relatively high promoter pledge to the extent of 16% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(09/05/2025)

108

Margin of Safety Index: Very High

50.00%

50.00% People are bullish about Nath Bio-Genes (India) Ltd

50.00%

50.00 % People are bearish about Nath Bio-Genes (India) Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %